Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis.
Saved in:
| Title: | Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis. |
|---|---|
| Authors: | Yang, Ming‐Han1 (AUTHOR), Huang, Chiun‐Sheng2,3 (AUTHOR), Chang, Dwan‐Ying1 (AUTHOR), Hu, Fu‐Chang4,5 (AUTHOR), Huang, Shu‐Min1 (AUTHOR), Huang, Po‐Hsiang1 (AUTHOR), Chen, I‐Chun1,6,7 (AUTHOR), Chen, Tom Wei‐Wu1,7 (AUTHOR), Lin, Ching‐Hung1,3,6 (AUTHOR), Lu, Yen‐Shen1,3 (AUTHOR) yslu@ntu.edu.tw |
| Source: | Cancer Medicine. Jul2024, Vol. 13 Issue 14, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 178684075 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Yang%2C+Ming‐Han%22">Yang, Ming‐Han</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Chiun‐Sheng%22">Huang, Chiun‐Sheng</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chang%2C+Dwan‐Ying%22">Chang, Dwan‐Ying</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Fu‐Chang%22">Hu, Fu‐Chang</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Shu‐Min%22">Huang, Shu‐Min</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Po‐Hsiang%22">Huang, Po‐Hsiang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+I‐Chun%22">Chen, I‐Chun</searchLink><relatesTo>1,6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Tom+Wei‐Wu%22">Chen, Tom Wei‐Wu</searchLink><relatesTo>1,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Ching‐Hung%22">Lin, Ching‐Hung</searchLink><relatesTo>1,3,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Yen‐Shen%22">Lu, Yen‐Shen</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> yslu@ntu.edu.tw</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Jul2024, Vol. 13 Issue 14, p1-12. 12p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=178684075 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cam4.70005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 1 Titles: – TitleFull: Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang, Ming‐Han – PersonEntity: Name: NameFull: Huang, Chiun‐Sheng – PersonEntity: Name: NameFull: Chang, Dwan‐Ying – PersonEntity: Name: NameFull: Hu, Fu‐Chang – PersonEntity: Name: NameFull: Huang, Shu‐Min – PersonEntity: Name: NameFull: Huang, Po‐Hsiang – PersonEntity: Name: NameFull: Chen, I‐Chun – PersonEntity: Name: NameFull: Chen, Tom Wei‐Wu – PersonEntity: Name: NameFull: Lin, Ching‐Hung – PersonEntity: Name: NameFull: Lu, Yen‐Shen IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 07 Text: Jul2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 20457634 Numbering: – Type: volume Value: 13 – Type: issue Value: 14 Titles: – TitleFull: Cancer Medicine Type: main |
| ResultId | 1 |